All Articles

Browse the full archive, newest first.

SCOTUStoday for Tuesday, April 7

Strategic angle: President Donald Trump is not done complaining about the Supreme Court’s tariffs ruling.

Stellantis’s Plan For Canada Looks Less Like A Car Factory And More Like A Chinese IKEA, Says Official

Strategic angle: Canadian industry leaders and politicians are pushing back hard on reports that Brampton could come back as a knockdown kit assembly operation.

Editorial Staff Apr 7

Money

Two Boxes raises $3.2M to scale AI returns platform

Strategic angle: Funding will help enhance AI-driven solutions for investment returns.

Editorial Staff Apr 7

Life

Health insurers score major win with higher 2027 Medicare Advantage rates

The stocks of major Medicare Advantage insurers surged on the announcement.

Editorial Staff Apr 7

Money

Polymarket Announces Upgrade And Native Stablecoin

Strategic angle: Polymarket unveils significant platform upgrades alongside the introduction of its native stablecoin.

Editorial Staff Apr 7

Environment

BP shareholders advised to vote against chair over climate resolution exclusion

Strategic angle: Glass Lewis raises transparency issues regarding AGM exclusion of climate resolution.

Editorial Staff Apr 7

Politics

Iran has attacked Saudi Arabia's Jubail petrochemical complex, IRGC says

Strategic angle: Iran's Revolutionary Guard Corps claims responsibility for the attack on a key petrochemical facility in Saudi Arabia.

Editorial Staff Apr 7

Politics

Trump's Iran ultimatum: when does it expire and how serious is his threat to 'blow up everything'?

Strategic angle: US president warns a civilisation could be about to disappear if the regime in Tehran does not respond to his ultimatum after six weeks of war by Tuesday night.

Editorial Staff Apr 7

Energy

Tyler Cowen: Why Oil Price Spikes Could Spark a Global Recession

Strategic angle: An analysis of the potential economic impacts of rising oil prices.

Editorial Staff Apr 7

Life

Capping Insulin Costs at $35 May Improve Treatment Adherence for Type 2 Diabetes

A recent study suggests that limiting insulin prices to $35 per month could enhance adherence to treatment among individuals with type 2 diabetes, highlighting the potential impact of cost on health outcomes.

Editorial Staff Apr 7